Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Liver transplantation in the United States, 1999-2008.

Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ.

Am J Transplant. 2010 Apr;10(4 Pt 2):1003-19. doi: 10.1111/j.1600-6143.2010.03037.x.

2.

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.

Veldt BJ, Poterucha JJ, Watt KD, Wiesner RH, Hay JE, Rosen CB, Heimbach JK, Janssen HL, Charlton MR.

Am J Transplant. 2009 Jun;9(6):1406-13. doi: 10.1111/j.1600-6143.2009.02642.x. Epub 2009 May 13.

3.

Effects of estradiol and progesterone on the proinflammatory cytokine production by mononuclear cells from patients with chronic hepatitis C.

Yuan Y, Shimizu I, Shen M, Aoyagi E, Takenaka H, Itagaki T, Urata M, Sannomiya K, Kohno N, Tamaki K, Shono M, Takayama T.

World J Gastroenterol. 2008 Apr 14;14(14):2200-7.

4.

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.

Berenguer M, Palau A, Aguilera V, Rayón JM, Juan FS, Prieto M.

Am J Transplant. 2008 Mar;8(3):679-87. doi: 10.1111/j.1600-6143.2007.02126.x.

5.

Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation.

Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, Frilling A, Malago M, Gerken G, Broelsch CE, Beckebaum S.

Transplantation. 2007 Jul 15;84(1):56-63.

PMID:
17627238
6.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

7.

A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.

Angelico M, Petrolati A, Lionetti R, Lenci I, Burra P, Donato MF, Merli M, Strazzabosco M, Tisone G.

J Hepatol. 2007 Jun;46(6):1009-17. Epub 2007 Feb 5.

PMID:
17328985
8.

Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients.

Velidedeoglu E, Mange KC, Frank A, Abt P, Desai NM, Markmann JW, Reddy R, Markmann JF.

Transplantation. 2004 Jun 27;77(12):1834-42.

PMID:
15223900
9.

Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.

Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.

Transplantation. 2004 Jan 27;77(2):226-31.

PMID:
14742986
10.

Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.

Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC.

Transplantation. 2004 Jan 15;77(1):84-92.

PMID:
14724440
11.

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C.

Gastroenterology. 2003 Mar;124(3):642-50.

PMID:
12612903
12.

The association between hepatitis C infection and survival after orthotopic liver transplantation.

Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR.

Gastroenterology. 2002 Apr;122(4):889-96.

PMID:
11910340
13.

The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D.

JAMA. 2000 Jul 26;284(4):450-6.

PMID:
10904508
15.

Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.

Yasuda M, Shimizu I, Shiba M, Ito S.

Hepatology. 1999 Mar;29(3):719-27.

PMID:
10051473
16.

Supplemental Content

Support Center